Home
Conditions
Hepatocellular Carcinoma Non-resectable

Clinical trial condition

Hepatocellular Carcinoma Non-resectable

Explore clinical trials studying Hepatocellular Carcinoma Non-resectable. Study availability and eligibility vary by location and protocol.

44 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma Non-resectable trial results

Recruiting

Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma

NCT04965454

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: The Queen's Medical Center Honolulu, Hawaii, United States

View Trial Details

Recruiting

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

NCT06904183

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)

NCT05911633

Conditions: Hepatocellular Carcinoma Non-resectable
Locations: CUB Hôpital Erasme Brussels, Belgium

UZ Leuven Leuven, Belgium

Beaujon Hospital Clichy, France

CHU Grenobles (Hôpital Michallon) La Tronche, France

View Trial Details

Recruiting

Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma

NCT04996914

Conditions: Hepatocellular Carcinoma Non-resectable
Locations: RWTH Aachen University Hospital Aachen, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

NCT07122089

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU de Grenoble Grenoble, France

CHU de Lille Lille, France

La Timone Marseille, France

CHU de Montpellier Montpellier, France

View Trial Details

Recruiting

Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma

NCT06133062

Conditions: Hepatocellular Carcinoma Non-resectable
Locations: Chang Gung Memorial Hospital at Linkou Taoyuan City, Taiwan

View Trial Details

Recruiting

Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC

NCT06904196

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

NCT05713994

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The Second Affiliated Hospital of Fujian Medical University Quanzhou, Fujian, China

TongjiHospital Wuhan, Hubei, China

View Trial Details

Recruiting

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

NCT05992220

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Recruiting

DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC

NCT06397235

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Hepatocellular Carcinoma Non-resectable

Hepatocellular Carcinoma Non-resectable trial results

Related conditions